

NCT00391690 Raw comparison:

Summary:
CHIA has 23 criteria while your personal folder has 25 criteria
Total found criteria: 23/23
Total not Found: 0/23
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Patients with histologically confirmed diagnosis   │ Patients with histologically confirmed diagnosis   │
│ of prostate cancer who have not yet developed bone │ of prostate cancer who have not yet developed bone │
│ metastases                                         │ metastases                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Prostate cancer patients with a rise in PSA under  │ Prostate cancer patients with a rise in PSA under  │
│ hormone therapy                                    │ hormone therapy                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ PSA criteria                                       │ PSA criteria                                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who have undergone prostatectomy any rise │ Patients who have undergone prostatectomy any rise │
│ in PSA or                                          │ in PSA or                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients without prostatectomy 2 consecutive rises │ Patients without prostatectomy 2 consecutive rises │
│ in PSA levels relative to a previous reference     │ in PSA levels relative to a previous reference     │
│ value separated by one month The first measurement │ value separated by one month The first measurement │
│ must occur one month after the reference value and │ must occur one month after the reference value and │
│ must be above the reference value The second       │ must be above the reference value The second       │
│ confirmatory measurement taken one month after the │ confirmatory measurement taken one month after the │
│ first measurement must be greater than the first   │ first measurement must be greater than the first   │
│ measurement                                        │ measurement                                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Previous chemotherapy or radiotherapy must have    │ Previous chemotherapy or radiotherapy must have    │
│ been performed ≥ 8 weeks prior to study entry      │ been performed ≥ 8 weeks prior to study entry      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Eastern Cooperative Oncology Group (ECOG) score of │ Eastern Cooperative Oncology Group (ECOG) score of │
│ 0 1 or 2 (patients that spend less than 50% of     │ 0 1 or 2 (patients that spend less than 50% of     │
│ time in bed during the day)                        │ time in bed during the day)                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Adequate liver function - serum total bilirubin    │ Adequate liver function - serum total bilirubin    │
│ concentration less than 1 5 x upper limit of       │ concentration less than 1 5 x upper limit of       │
│ normal value                                       │ normal value                                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Age ≥ 18 years                                     │ Age ≥ 18 years                                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient has given written informed consent prior   │ Patient has given written informed consent prior   │
│ to any study-specific procedures Patients with     │ to any study-specific procedures Patients with     │
│ psychiatric or addictive disorders which prevent   │ psychiatric or addictive disorders which prevent   │
│ them from giving their informed consent must not   │ them from giving their informed consent must not   │
│ enter the study                                    │ enter the study                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Prior treatment with a bisphosphonate              │ Prior treatment with a bisphosphonate              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Abnormal renal function as evidenced by a          │ Abnormal renal function as evidenced by a          │
│ calculated creatinine clearance < 30 ml/minute     │ calculated creatinine clearance \< 30 ml/minute    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Corrected (adjusted for serum albumin) serum       │ Corrected (adjusted for serum albumin) serum       │
│ calcium concentration < 8 0 mg/dl (2 00 mmol/L) or │ calcium concentration \< 8 0 mg/dl (2 00 mmol/L)   │
│ ≥ 12 0 mg/dl (3 00 mmol/L)                         │ or ≥ 12 0 mg/dl (3 00 mmol/L)                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with clinically symptomatic brain         │ Patients with clinically symptomatic brain         │
│ metastases                                         │ metastases                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of diseases with influence on bone         │ History of diseases with influence on bone         │
│ metabolism such as Paget's disease and primary     │ metabolism such as Paget's disease and primary     │
│ hyperparathyroidism                                │ hyperparathyroidism                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Severe physical or psychological concomitant       │ Severe physical or psychological concomitant       │
│ diseases that might impair compliance with the     │ diseases that might impair compliance with the     │
│ provisions of the study protocol or that might     │ provisions of the study protocol or that might     │
│ impair the assessment of drug or patient safety e  │ impair the assessment of drug or patient safety e  │
│ g clinically significant ascites cardiac failure   │ g clinically significant ascites cardiac failure   │
│ NYHA III or IV clinically relevant pathologic      │ NYHA III or IV clinically relevant pathologic      │
│ findings in ECG                                    │ findings in ECG                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known hypersensitivity to zoledronic acid or other │ Known hypersensitivity to zoledronic acid or other │
│ bisphosphonates                                    │ bisphosphonates                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Use of other investigational drugs 30 days prior   │ Use of other investigational drugs 30 days prior   │
│ to the date of randomization                       │ to the date of randomization                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known history or present abuse of alcohol or drugs │ Known history or present abuse of alcohol or drugs │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects who in the opinion of the investigator    │ Subjects who in the opinion of the investigator    │
│ are unlikely to cooperate fully during the study   │ are unlikely to cooperate fully during the study   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current active dental problems including infection │ Current active dental problems including infection │
│ of the teeth or jawbone (maxilla or mandibular)    │ of the teeth or jawbone (maxilla or mandibular)    │
│ dental or fixture trauma or a current or prior     │ dental or fixture trauma or a current or prior     │
│ diagnosis of osteonecrosis of the jaw (ONJ) of     │ diagnosis of osteonecrosis of the jaw (ONJ) of     │
│ exposed bone in the mouth or of slow healing after │ exposed bone in the mouth or of slow healing after │
│ dental procedures                                  │ dental procedures                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Recent (within 6 weeks) or planned dental or jaw   │ Recent (within 6 weeks) or planned dental or jaw   │
│ surgery (e g extraction implants)                  │ surgery (e g extraction implants)                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Other protocol defined inclusion/exclusion         │ Other protocol defined inclusion/exclusion         │
│ criteria may apply                                 │ criteria may apply                                 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must be MALE                      │
├───────────────────────────────────┤
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛